Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Combination of lapatinib and trastuzumab more effective in treating HER2-positive breast cancer

Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent. In a report in the January 17 issue of The Lancet, an international research team reports that a protocol adding lapatinib (Tykerb) to trastuzumab (Herceptin) was more effective than single-drug treatment with either drug in eliminating microscopic signs of cancer at the time the tumors were surgically removed.

17 Jan 2012

Matted lymph nodes may predict throat cancer metastasis

Researchers at the University of Michigan Health System have found a new indicator that may predict which patients with a common type of throat cancer are most likely have the cancer spread to other parts of their bodies.

17 Jan 2012

Cancer researcher identifies high levels of doctor-patient trust and confidence within NHS

A leading cancer researcher has identified very high levels of doctor-patient trust and confidence within the NHS.

16 Jan 2012

Links between deodorants and breast cancer refuted but more information needed: Study

A chemical present in cosmetics, food products and pharmaceuticals has been found in tissue samples from 40 women with breast cancer. A number of studies since 1998 have raised concerns about the potential role of these chemicals called parabens in breast cancer as they possess estrogenic properties. Estrogen is known to play a central role in the development, growth and progression of breast cancer.

16 Jan 2012

Processed meat and pancreatic cancer risk: Study

Swedish researchers have found a link between eating processed meat, such as bacon or sausages, and pancreatic cancer. They said eating an extra 50g of processed meat, approximately one sausage, every day would increase a person's risk of getting pancreatic cancer by 19%. But the chance of developing the rare cancer remains low they added.

16 Jan 2012

NimbleGen Sequence Capture 385K array identifies gene mutations linked with hereditary hearing loss

Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the Institute of Human Genetics at the University Hospital Jena, Germany, used a number of different methods, including Roche's NimbleGen Custom Sequence Capture 385K array to identify the gene mutated in the disease locus of the X-chromosome of a Spanish family with hereditary hearing loss.

13 Jan 2012

Cabazitaxel with IMRT, androgen deprivation therapy may extend survival for prostate cancer patients

Jefferson's Kimmel Cancer Center has started a Phase I clinical trial investigating the latest prostate cancer chemotherapy drug to extend survival, Cabazitaxel, in combination with radiation and hormone therapy. This first-of-its-kind multimodality approach could improve disease control and eventually survival for locally advanced prostate cancer patients.

13 Jan 2012

Genetic link to prostate cancer discovered

A new study has found that men who inherit a rare genetic mutation are 10 to 20 times more likely than average to develop prostate cancer. The gene variant may help explain cases of the disease that run in families and strike men at unusually young ages.

12 Jan 2012

APHON receives prestigious Gold Award in Association TRENDS' 2011 All-Media Contest

APHON has been honored with a Gold in Educational Program in Association TRENDS' 2011 All-Media Contest. It was one of more than 450 entries in the association publications contest.

12 Jan 2012

Chemotherapy drugs can lead to relapse of leukemia

The chemotherapy drugs required to push a common form of adult leukemia into remission may contribute to DNA damage that can lead to a relapse of the disease in some patients, findings of a new study suggest.

12 Jan 2012

UBM Medica's cancer care reference book now available online

UBM Medica's widely acclaimed and trusted cancer care reference book Cancer Management: A Multidisciplinary Approach, 14th edition, is now available online. This guide is designed to present important clinical information concisely, uniformly, and logically, emphasizing the natural history of the malignancy, screening and diagnosis, staging and prognosis, and treatment of cancers.

12 Jan 2012

FDA clears Roche's Accu-Chek Nano SmartView blood glucose monitoring system

Roche announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Accu-Chek Nano SmartView blood glucose monitoring system.

12 Jan 2012

Scientists identify rare genetic mutation linked to prostate cancer

After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease.

12 Jan 2012

$Merrimack commences MM-151 Phase 1 trial in refractory advanced solid tumors$

Merrimack commences MM-151 Phase 1 trial in refractory advanced solid tumors

Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 1 clinical trial of MM-151, an oligoclonal therapeutic consisting of a mixture of three fully human monoclonal antibodies designed to bind to non-overlapping epitopes of the epidermal growth factor receptor.

11 Jan 2012

Saladax increases claims in immunoassay space to 15 patents

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that it has been issued six patents within the last 12 months, bringing the company's total to 15 issued U.S. patents, all of which contain broad claims in the immunoassay space.

11 Jan 2012

UCSF, Sanofi enter $3.1 million collaboration to identify diabetes drug targets

The University of California, San Francisco has signed an alliance with international pharmaceutical company Sanofi to share expertise in diabetes research and identify drug targets that could lead to new therapies for both type 1 and type 2 diabetes.

11 Jan 2012

Bladder cancer is one of the top 10 most common forms of cancer in the US

Bladder cancer, most frequently caused by smoking and exposure to carcinogens in the workplace, is one of the top 10 most common forms of cancer in men and women in the U.S. More than 70 percent of bladder cancers are diagnosed in stage T1 or less and have not invaded the muscle layer.

11 Jan 2012

Inherited breast and ovarian cancer drug trial re-launched in tablet form

Cancer Research UK's Drug Development Office has re-launched a trial of a promising drug to treat inherited breast and ovarian cancer - but this time taken as a tablet by outpatients.

11 Jan 2012

FDA grants 510(k) clearance for Varian's new radiotherapy treatment planning tool

Varian Medical Systems has received FDA 510(k) clearance for a new radiotherapy treatment planning tool designed to work with the company's market leading Eclipse™ treatment planning software to reduce the amount of time needed for planning advanced treatments.

11 Jan 2012

Foundation Medicine, Sanofi enter strategic collaboration for cancer genome analysis

Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genome analysis to routine clinical care, today announced the initiation of a strategic collaboration with Sanofi.

11 Jan 2012

Oncology News and Research

Further Reading

Combination of lapatinib and trastuzumab more effective in treating HER2-positive breast cancer

Matted lymph nodes may predict throat cancer metastasis

Cancer researcher identifies high levels of doctor-patient trust and confidence within NHS

Links between deodorants and breast cancer refuted but more information needed: Study

Processed meat and pancreatic cancer risk: Study

NimbleGen Sequence Capture 385K array identifies gene mutations linked with hereditary hearing loss

Cabazitaxel with IMRT, androgen deprivation therapy may extend survival for prostate cancer patients

Genetic link to prostate cancer discovered

APHON receives prestigious Gold Award in Association TRENDS' 2011 All-Media Contest

Chemotherapy drugs can lead to relapse of leukemia

UBM Medica's cancer care reference book now available online

FDA clears Roche's Accu-Chek Nano SmartView blood glucose monitoring system

Scientists identify rare genetic mutation linked to prostate cancer

Merrimack commences MM-151 Phase 1 trial in refractory advanced solid tumors

Saladax increases claims in immunoassay space to 15 patents

UCSF, Sanofi enter $3.1 million collaboration to identify diabetes drug targets

Bladder cancer is one of the top 10 most common forms of cancer in the US

Inherited breast and ovarian cancer drug trial re-launched in tablet form

FDA grants 510(k) clearance for Varian's new radiotherapy treatment planning tool

Foundation Medicine, Sanofi enter strategic collaboration for cancer genome analysis

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News